Per Aniansson
Member of Board
Medical Science
Scibase
Sweden
Biography
Per Aniansson is an Investment Director at Fouriertransform AB and has been a member of the Board since 2014. He holds an MSc Engineering Physics from Chalmers University of Technology and an MBA from INSEAD. Mr Aniansson has 20 years of experience in life science and investments ranging from start-ups to large public companies. He has previously held positions at Industrivärden, Siemens and Innovationskapital. Mr Aniansson has six years of experience as management consultant at Accenture and Arthur D Little, mainly with a focus in the Pharma and Medtech business. He also has entrepreneurial experience as a CEO in two UK based medtech companies, one within medical devices (Syringes) and one within IVD and devices targeting the colorectal cancer diagnostics market. Current assignments: Investment director at Fouriertransform Aktiebolag. Member of the Boards of Ossdsign AB, Origin Sciences Ltd., Star Syringe Ltd., Stiftelsen Bota Cancer, ÅAC Microtec AB, Renewcell AB and Anian AB.
Research Interest
His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.
